COMPOSTO DE FÓRMULA I; COMPOSTO DE FÓRMULA IV; COMPOSIÇÃO; USO DE UM COMPOSTO NA PREPARAÇÃO DE UM MEDICAMENTO PARA O TRATAMENTO E PREVENÇÃO DE UMA CONDIÇÃO; PROCESSO PARA A PREPARAÇÃO DE UM COMPOSTO DA FÓRMULA I; E PROCESSO PARA A PREPARAÇÃO DE UM COMPOSTO DA FÓRMULA III

The present invention is directed to aryl sulfamide derivatives of formula I: or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of cond...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CASEY CAMERON MC COMAS, JOEL ADAM GOLDBERG, PUWEN ZHANG, JOSEPH P. SABATUCCI, PAIGE ERIN MAHANEY, ANDREW FENSOME, CHARLES WILLIAM MANN, EUGENE ANTHONY TEREFENKO, DOUGLAS JOHN JENKINS, RICHARD PAGE WOODWORTH JR, EUGENE JOHN TRYBULSKI, MATTHEW L. CRAWLEY, MICHAEL ANTHONY MARELLA, STEPHEN TODD COHN, AN THIEN VU, CALLAIN YOUNGHEE KIM, DAVID JOHN O'NEILL
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is directed to aryl sulfamide derivatives of formula I: or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders.